(2S,3R,4S,5S,6R)-2-[(2S,3R,4S,5S,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-2-[(2R,3R,4R,5R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol

Metabolite details

Identifier

XVZKICWMWKGCOD-GJVUERLISA-N

InChI Key

XVZKICWMWKGCOD-GJVUERLISA-N

IUPAC name

Preferred name

(2S,3R,4S,5S,6R)-2-[(2S,3R,4S,5S,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-2-[(2R,3R,4R,5R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol

INN name

—

Synonym

beta-D-gluco-hexopyranosyl-(1->2)-beta-D-gluco-hexopyranosyl-(1->4)-D-galacto-hexopyranose

ChEBI

CHEBI:150343

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Unknown Metabolite Annotation in Mouse Aging using Ion Mobility Collision Cross-Section Atlas (AllCCS)

Observed in differential profiles

• 36_week_vs_104_week